The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2020
Filed:
Apr. 03, 2017
Applicants:
The Brigham and Women's Hospital, Inc., Boston, MA (US);
Celera Corporation, Alameda, CA (US);
Inventors:
Paul M. Ridker, Chestnut Hill, MA (US);
Daniel Chasman, Cambridge, MA (US);
Dov Shiffman, Palo Alto, CA (US);
Assignees:
The Brigham and Women's Hospital, Inc., Boston, MA (US);
Celera Corporation, Alameda, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12Q 1/68 (2018.01); C12Q 1/6883 (2018.01); G01N 33/92 (2006.01); A61K 31/616 (2006.01); C12Q 1/6876 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); A61K 31/616 (2013.01); C12Q 1/6876 (2013.01); G01N 33/92 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/172 (2013.01); G01N 2333/775 (2013.01); G01N 2500/04 (2013.01); G01N 2800/32 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01);
Abstract
This invention relates to nucleotide polymorphisms in the human Apo(a) gene and to the use of Apo(a) nucleotide polymorphisms in identifying whether a human subject will respond or not to treatment with acetylsalicylic acid.